These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28343767)

  • 41. Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy.
    Kallwellis-Opara A; Staudt A; Trimpert C; Noutsias M; Kühl U; Pauschinger M; Schultheiss HP; Grube M; Böhm M; Baumann G; Völker U; Kroemer HK; Felix SB
    J Mol Med (Berl); 2007 Dec; 85(12):1429-35. PubMed ID: 17924085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure.
    Devaux B; Scholz D; Hirche A; Klövekorn WP; Schaper J
    Eur Heart J; 1997 Mar; 18(3):470-9. PubMed ID: 9076385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.
    Kühl U; Noutsias M; Seeberg B; Schultheiss HP
    Heart; 1996 Mar; 75(3):295-300. PubMed ID: 8800996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M; Svezia B; Matteucci M; Botta L; Pucci A; Rinaldi M; Caselli C; Lionetti V; Del Ry S
    PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome.
    Escher F; Kühl U; Lassner D; Stroux A; Westermann D; Skurk C; Tschöpe C; Poller W; Schultheiss HP
    Eur J Heart Fail; 2014 Oct; 16(10):1066-72. PubMed ID: 25163698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radixin Relocalization and Nonmuscle
    Cetinkaya A; Berge B; Sen-Hild B; Troidl K; Gajawada P; Kubin N; Valeske K; Schranz D; Akintürk H; Schönburg M; Kubin T; Choi YH; Richter M
    Dis Markers; 2020; 2020():9356738. PubMed ID: 32774516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy].
    Cortés R; Portolés M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Salvador A; Rivera M
    Rev Esp Cardiol; 2007 Dec; 60(12):1319-23. PubMed ID: 18082099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In situ nuclear DNA methylation in dilated cardiomyopathy: an endomyocardial biopsy study.
    Watanabe T; Okada H; Kanamori H; Miyazaki N; Tsujimoto A; Takada C; Suzuki K; Naruse G; Yoshida A; Nawa T; Tanaka T; Kawasaki M; Ito H; Ogura S; Okura H; Fujiwara T; Fujiwara H; Takemura G
    ESC Heart Fail; 2020 Apr; 7(2):493-502. PubMed ID: 31971668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MD-2 is a new predictive biomarker in dilated cardiomyopathy and exerts direct effects in isolated cardiomyocytes.
    Riad A; Gross S; Witte J; Feldtmann R; Wagner KB; Reinke Y; Weitmann K; Empen K; Beug D; Westermann D; Lindner D; Klingel K; Dörr M; Hoffmann W; Felix SB
    Int J Cardiol; 2018 Nov; 270():278-286. PubMed ID: 30082120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence.
    Gonzalez-Valdes I; Hidalgo I; Bujarrabal A; Lara-Pezzi E; Padron-Barthe L; Garcia-Pavia P; Gómez-del Arco P; Redondo JM; Ruiz-Cabello JM; Jimenez-Borreguero LJ; Enriquez JA; de la Pompa JL; Hidalgo A; Gonzalez S
    Nat Commun; 2015 Mar; 6():6473. PubMed ID: 25751743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy.
    Sun X; Shan A; Wei Z; Xu B
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2611-2618. PubMed ID: 30126637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical variables associated with the presence of inflammatory infiltrates in patients with dilated cardiomyopathy undergoing heart transplantation.
    Agüero J; Navarro J; Medina MC; Almenar L; Chirivella M; Martínez-Dolz L; Moro JA; Sánchez-Lazaro I; Ortiz V; Raso R; Salvador A
    Transplant Proc; 2008 Nov; 40(9):3017-9. PubMed ID: 19010177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy.
    Zhang Y; Zhang M; Xu W; Chen J; Zhou X
    Oncotarget; 2017 Apr; 8(17):28588-28594. PubMed ID: 28430627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A possible role for complement in the pathogenesis of chronic chagasic cardiomyopathy.
    Aiello VD; Reis MM; Benvenuti LA; Higuchi Mde L; Ramires JA; Halperin JA
    J Pathol; 2002 Jun; 197(2):224-9. PubMed ID: 12015747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy.
    Francis SE; Holden H; Holt CM; Duff GW
    J Mol Cell Cardiol; 1998 Feb; 30(2):215-23. PubMed ID: 9514998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix remodelling in dilated cardiomyopathy entails the occurrence of oncofetal fibronectin molecular variants.
    Gabler U; Berndt A; Kosmehl H; Mandel U; Zardi L; Müller S; Stelzner A; Katenkamp D
    Heart; 1996 Apr; 75(4):358-62. PubMed ID: 8705761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.